JP2022539400A5 - - Google Patents

Info

Publication number
JP2022539400A5
JP2022539400A5 JP2021578068A JP2021578068A JP2022539400A5 JP 2022539400 A5 JP2022539400 A5 JP 2022539400A5 JP 2021578068 A JP2021578068 A JP 2021578068A JP 2021578068 A JP2021578068 A JP 2021578068A JP 2022539400 A5 JP2022539400 A5 JP 2022539400A5
Authority
JP
Japan
Prior art keywords
methyl
bis
biphenyl
alkyl
pentyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021578068A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022539400A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2020/050932 external-priority patent/WO2021000053A1/en
Publication of JP2022539400A publication Critical patent/JP2022539400A/ja
Publication of JP2022539400A5 publication Critical patent/JP2022539400A5/ja
Pending legal-status Critical Current

Links

JP2021578068A 2019-07-04 2020-07-03 カンナビノイド誘導体 Pending JP2022539400A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201962870743P 2019-07-04 2019-07-04
US62/870,743 2019-07-04
US201962934318P 2019-11-12 2019-11-12
US62/934,318 2019-11-12
US202062966421P 2020-01-27 2020-01-27
US62/966,421 2020-01-27
PCT/CA2020/050932 WO2021000053A1 (en) 2019-07-04 2020-07-03 Cannabinoid derivatives

Publications (2)

Publication Number Publication Date
JP2022539400A JP2022539400A (ja) 2022-09-08
JP2022539400A5 true JP2022539400A5 (cg-RX-API-DMAC10.html) 2023-07-10

Family

ID=74100116

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021578068A Pending JP2022539400A (ja) 2019-07-04 2020-07-03 カンナビノイド誘導体

Country Status (4)

Country Link
US (1) US12630492B2 (cg-RX-API-DMAC10.html)
EP (1) EP3994114A4 (cg-RX-API-DMAC10.html)
JP (1) JP2022539400A (cg-RX-API-DMAC10.html)
WO (1) WO2021000053A1 (cg-RX-API-DMAC10.html)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021007661A1 (en) 2019-07-12 2021-01-21 Canopy Growth Corporation Cannabinoid derivatives
EP3997098A4 (en) 2019-07-12 2023-10-11 Canopy Growth Corporation Cannabinoid derivatives
WO2021007663A1 (en) 2019-07-12 2021-01-21 Canopy Growth Corporation Cannabinoid derivatives
JP2022551066A (ja) 2019-10-02 2022-12-07 キャノピー グロウス コーポレイション カンナビノイド誘導体
US12084407B2 (en) 2019-11-26 2024-09-10 Canopy Growth Corporation Cannabigerol derivatives and use thereof as cannabinoid receptor modulators
US12617765B2 (en) 2019-12-09 2026-05-05 Canopy Growth Corporation Cannabinoid derivatives
IL312785B2 (en) 2020-05-19 2026-06-01 Cybin Irl Ltd Deuterated tryptamine derivatives and methods of use
EP4243774A4 (en) * 2020-11-16 2024-11-06 Synergy Life Science, Inc. Cannabinoid emulsifier
CN112898190B (zh) * 2021-02-07 2023-10-24 中国科学院长春应用化学研究所 一种大麻二酚衍生物及其制备方法
TWI894435B (zh) * 2021-02-26 2025-08-21 日商丸善石油化學股份有限公司 縮醛化合物、含有該化合物之添加劑及含有該化合物之阻劑用組成物
CN113087661B (zh) * 2021-03-24 2022-09-06 福建省中科生物股份有限公司 一种2’,6’-双吡啶取代大麻二酚醚类化合物及其制备方法和用途
CN113149897B (zh) * 2021-03-24 2023-10-31 福建省中科生物股份有限公司 一种2,6-取代-4-氧基萜酚吡啶类化合物及其制备方法和用途
CN115315418B (zh) * 2021-04-06 2023-03-21 山东绿叶制药有限公司 大麻二酚前药及其药物组合物和应用
AU2022324615A1 (en) * 2021-08-04 2024-02-15 Demeetra Agbio, Inc. Cannabinoid derivatives and their use
CN116253671B (zh) * 2021-12-10 2025-07-04 德义制药有限公司 一种大麻二酚衍生物及其制备方法和应用
US20260193222A1 (en) * 2022-12-02 2026-07-09 Benethera (Shaoxing) Biotechnology Co., Ltd. Compound and use thereof in treatment of treg-related diseases
WO2026038872A1 (ko) * 2024-08-13 2026-02-19 주식회사 네오켄바이오 신규한 화합물 및 이의 용도

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1643366A1 (de) * 1967-10-04 1971-06-09 Bayer Ag Verfahren zur Herstellung von Phenol-Halbformalen
EP0119457B1 (de) 1983-02-23 1986-12-30 Bayer Ag Mittel zur Regulierung des Pflanzenwachstums
DE3306201A1 (de) 1983-02-23 1984-08-23 Bayer Ag, 5090 Leverkusen Mittel zur regulierung des pflanzenwachstums
EP1071419B1 (en) 1998-04-21 2007-07-25 THE UNITED STATES GOVERNMENT as represented by THE DEPARTMENT OF HEALTH AND HUMAN SERVICES Cannabinoids as antioxidants and neuroprotectants
US6566560B2 (en) * 1999-03-22 2003-05-20 Immugen Pharmaceuticals, Inc. Resorcinolic compounds
US7285687B2 (en) 2002-04-25 2007-10-23 Virginia Commonwealth University Cannabinoids
PT2473475T (pt) 2009-08-31 2017-08-02 Zynerba Pharmaceuticals Inc Utilização de profármacos de canabidiol na administração tópica e transdérmica com microagulhas
WO2014039042A1 (en) 2012-09-06 2014-03-13 Northeastern University Novel cannabinergic compounds and uses thereof
US9517989B2 (en) 2012-10-17 2016-12-13 Northeastern University 2-cycloalkyl resorcinol cannabinergic ligands
JP6676176B2 (ja) 2016-01-29 2020-04-08 ユニヴァーシティー オブ ミシシッピ 生物学的に活性なカンナビジオール類似体
CN109311838A (zh) * 2016-04-15 2019-02-05 蒂温诺特技术有限公司 大麻素前药的生物合成
CN109069475B (zh) 2016-04-22 2022-01-28 受体控股公司 快速作用植物类医药化合物和营养补剂
JP2018162231A (ja) 2017-03-27 2018-10-18 三井化学株式会社 遷移金属化合物、オレフィン重合用触媒およびオレフィン系重合体の製造方法
WO2020107119A1 (en) 2018-11-30 2020-06-04 Canopy Growth Corporation Compositions comprising a cannabinoid or a cannabis-derived compound, methods of making and use
CA3138732A1 (en) 2018-11-30 2020-06-04 Canopy Growth Corporation Water-soluble formulations of cannabinoids or cannabis-derived compounds, methods of making and use
US20220242844A1 (en) 2019-07-04 2022-08-04 Canopy Growth Corporation Cannabinoid derivatives
WO2021007659A1 (en) 2019-07-12 2021-01-21 Canopy Growth Corporation Cannabinoid derivatives
WO2021007663A1 (en) 2019-07-12 2021-01-21 Canopy Growth Corporation Cannabinoid derivatives
WO2021007661A1 (en) 2019-07-12 2021-01-21 Canopy Growth Corporation Cannabinoid derivatives
WO2021007660A1 (en) 2019-07-12 2021-01-21 Canopy Growth Corporation Cannabinoid derivatives
EP3997098A4 (en) 2019-07-12 2023-10-11 Canopy Growth Corporation Cannabinoid derivatives
WO2021062557A1 (en) 2019-10-02 2021-04-08 Canopy Growth Corporation Cannabinoid derivatives
JP2022551066A (ja) 2019-10-02 2022-12-07 キャノピー グロウス コーポレイション カンナビノイド誘導体
US12084407B2 (en) 2019-11-26 2024-09-10 Canopy Growth Corporation Cannabigerol derivatives and use thereof as cannabinoid receptor modulators
US20230122510A1 (en) 2019-11-26 2023-04-20 Canopy Growth Corporation Cannabinoid derivatives
US20230059582A1 (en) 2019-12-09 2023-02-23 Canopy Growth Corporation Cannabinoid derivatives
US12617765B2 (en) 2019-12-09 2026-05-05 Canopy Growth Corporation Cannabinoid derivatives

Similar Documents

Publication Publication Date Title
JP2023505513A5 (cg-RX-API-DMAC10.html)
JP2022540432A5 (cg-RX-API-DMAC10.html)
JP2022540585A5 (cg-RX-API-DMAC10.html)
JP2022540434A5 (cg-RX-API-DMAC10.html)
JP2022551067A5 (cg-RX-API-DMAC10.html)
JP2022539401A5 (cg-RX-API-DMAC10.html)
JP2023503601A5 (cg-RX-API-DMAC10.html)
JP2022551066A5 (cg-RX-API-DMAC10.html)
JP2022540586A5 (cg-RX-API-DMAC10.html)
CN113365997A (zh) 作为c-Met抑制剂的含嘧啶基团的三并环类化合物
CA3087912C (en) Prodrugs of ketamine, compositions and uses thereof
JP2023503331A5 (cg-RX-API-DMAC10.html)
RU2341515C2 (ru) Ацетиленовые производные, способ их получения, фармацевтическая композиция на их основе и их применение в качестве антагонистов метаботропных глутаматных рецепторов (mglur5)
JP2023503330A5 (cg-RX-API-DMAC10.html)
JP2015516420A5 (cg-RX-API-DMAC10.html)
IL287159B1 (en) Small molecules agonists for FXR (farnesoid X receptor) and method for their preparation and use
AR074184A1 (es) Compuestos de 7-azaspiro[3.5]nonano-7-carboxamida, composiciones farmaceuticas que los comprenden y su uso en la fabricacion de medicamentos para el tratamiento de afecciones mediadas por la inhibicion de faah
JP2022512482A5 (cg-RX-API-DMAC10.html)
NL1028087C2 (nl) Sulfonamiderivaten voor de behandeling van ziekten.
JP5342451B2 (ja) Pde4阻害剤として有用な置換アセトフェノン
CA2001160C (en) Pyridine derivatives
JP6813626B2 (ja) グルコシルセラミド合成酵素阻害剤の製造方法
JP2016515096A5 (cg-RX-API-DMAC10.html)
SK284068B6 (sk) Ester odvodený od substituovanej fenylcyklohexylovej zlúčeniny, spôsob jeho prípravy a použitie
JP2022540433A5 (cg-RX-API-DMAC10.html)